山莨菪碱对血管内皮细胞组织因子和纤溶酶原激活物抑制剂1表达的影响及其机制研究 |
| |
引用本文: | 阮秋蓉,宋建新,邓仲端,瞿智玲.山莨菪碱对血管内皮细胞组织因子和纤溶酶原激活物抑制剂1表达的影响及其机制研究[J].中国中西医结合杂志,2004,24(5):422-426. |
| |
作者姓名: | 阮秋蓉 宋建新 邓仲端 瞿智玲 |
| |
作者单位: | 1. 华中科技大学同济医学院病理学教研室,武汉430030 2. 同济医学院附属同济医院 |
| |
基金项目: | 国家自然科学基金,湖北省武汉市科技局科研项目 |
| |
摘 要: | 目的 通过研究山莨菪碱对内毒素脂多糖(LPS)致血管内皮细胞组织因子(TF)和纤溶酶原激活物抑制剂1(PAI—1)表达的影响,探讨山莨菪碱治疗感染性休克的机制。方法 用酶消化法培养人脐静脉内皮细胞(HUVEC);ELISA方法检测HUVEC条件培养液PAI—1蛋白量:用一步凝固法检测HUVEC TF活性;Northern blot检测HUVEC TF和PAI—1的mRNA表达;为了评估上述作用是否通过NF—κB途径而转导,用电泳迁移变动检测法(EMSA)检测HUVEC核提取物NF—κB DNA结合活性。结果 LPS能使HUVEC PAI—1蛋白和TF活性及其mRNA表达显著增强,加入山莨菪碱后,LPS的这种作用明显减弱,并与山莨菪碱呈量效关系。山莨菪碱能完全阻止LPS致内皮细胞核提取物NF—κB DNA结合活性。结论 山莨菪碱治疗感染性休克的机制之一可能是通过拮抗LPS致HUVEC TF和PAI—1的表达。而且这种拮抗作用可能通过NF—κB途径来转导。
|
关 键 词: | 山莨菪碱 血管内皮细胞组织因子 纤溶酶原激活物抑制剂1 PAI-1 内毒素 |
修稿时间: | 2003年7月5日 |
Study on Effect of Anisodamine on Expressions of Tissue Factor and Plasminogen Activator-1 Inhibitor in Vascular Endothelial Cells and Its Mechanisms |
| |
Authors: | RUAN Qiu-rong SONG Jian-xin DENG Zhong-duan |
| |
Abstract: | OBJECTIVE: To explore the mechanism of anisodamine in treating infectious shock through studying effect of anisodamine on endotoxin lipopolysaccharide (LPS) induced expression of tissue factor (TF) and plasminogen activator inhibitor type 1 (PAI-1) in vascular endothelial cells (EC). METHODS: Human umbilical vein endothelial cells (HUVEC) were cultured by trypsin digestion method. PAI-1 was measured in the conditioned medium of HUVEC by a specific enzyme-linked immunosorbent assay (ELISA), whereas TF activity was measured in the lysates of these cells by using a single step clotting assay. Specific mRNA expressions were determined by Northern blotting. In order to evaluate a possible contribution of the nuclear factor-kappa B (NF-kappa B) pathway on the transductive effects observed, electrophoretic mobility shift assays (EMSA) were performed using nuclear extracts from HUVEC and NF-kappa B binding oligonucleotides. RESULTS: LPS could significantly strengthen the expression of HUVEC PAI-1 protein and TF activity and its mRNA, this effect of LPS could be markedly weakened after adding Anisodamine dose-dependently. Anisodamine could also completely block the LPS induced NF-kappa B DNA binding activity in nuclear extracts from HUVEC. CONCLUSION: The possible mechanism of anisodamine in treating infectious shock may be through antagonizing LPS induced HUVEC TF and PAI-1 expression, and the antagonism might be, at least partially, transduced by path of NF-kappa B. |
| |
Keywords: | |
本文献已被 CNKI 维普 万方数据 等数据库收录! |
| 点击此处可从《中国中西医结合杂志》浏览原始摘要信息 |
|
点击此处可从《中国中西医结合杂志》下载全文 |